The New York Times debunked research cited in Wana Brands’ marketing materials for its Fit gummies. Marketing materials said 100 out of 100 of participants who took the brand’s cannabinoid-packed weight loss gummies lost weight in a trial performed under the guidance of the Mayo Clinic. The Mayo Clinic, however, has no record of the research. Read on at The New York Times.

Analysts slashed revenue expectations for sales forecasts for New York-based Tilray, Ontario-based Canopy Growth and Alberta-headquartered Aurora Cannabis by hundreds of millions of dollars, affecting marijuana and cannabis derived products. Smaller, nimbler rivals have taken their toll, say analysts, but that’s not the only reason. Learn what else darkened the forecast at MJBizDaily.

Check out five charts by MJBizDaily that visually tell the story of the unpredictable year, including finance, legislation and cannabinoid expansion. Politics and the pandemic combined for sustained turbulence. Take a look and learn how last year’s ups and downs sets the industry up for 2022.